Bank of America analysts downgraded the stock to neutral from buy.
You are here: Home / Top Stories / : As COVID vaccine and Paxlovid sales decline, analysts want to know what’s next for Pfizer
Market News and Views
Bank of America analysts downgraded the stock to neutral from buy.